Plant polyphenols as broad-spectrum antivirals: Comprehensive potency profiling against major virus families
Abstract
Plant polyphenols are promising candidates for broad-spectrum antiviral development, but their comparative potency and selectivity across virus families remain poorly characterized. This study aims to systematically compare and profile the antiviral activity, potency, and selectivity of diverse plant polyphenol classes across major virus families relevant to human and animal health. A comprehensive literature search was conducted across five databases to identify studies reporting in vitro and in vivo antiviral activity of plant polyphenols, extracting quantitative IC₅₀/EC₅₀ and selectivity index data. Potency matrices were constructed, and comparative visualizations, including heatmaps, violin plots, and radar charts, were generated to assess the spectrum and strength of antiviral effects. Analysis of 54 studies revealed that flavonoids, catechins, phlorotannins, and biflavonoids frequently exhibit sub- to low-micromolar IC₅₀/EC₅₀ values against multiple virus families, particularly Orthomyxoviridae, Flaviviridae, and Coronaviridae. Certain scaffolds, such as dieckol and quercetin, demonstrated potent and broad activity (median IC₅₀ <10 µM) with favorable selectivity indices. In vivo efficacy data, though limited, confirmed survival or viral load reductions in animal models. The findings highlight several polyphenol scaffolds with robust, multi-family antiviral activity and high selectivity, underscoring their potential for broad-spectrum antiviral drug discovery. Considering all, standardized evaluation and further translational research are warranted to optimize lead candidates.
References
- [1]Besednova NN, Andryukov BG, et al. Antiviral Effects of Polyphenols from Marine Algae. Biomedicines. 2021;9:200.
- [2]Orosco FL, Dapar MLG. Exploring the Antiviral Potential of Polyphenols against Re-emerging and Emerging Viral Infections: A Comprehensive Review. J Nat Remedies. 2024:1403–1424.
- [3]Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013;2013:162750.
- [4]Orosco F, Quimque M. Antiviral potential of terpenoids against major viral infections: Recent advances, challenges, and opportunities. J Adv Biotechnol Exp Ther. 2024;7:221.
- [5]Orosco FL, Wong JE. Andrographolides as Antiviral Agents: Insights into Mechanisms, Modifications, and Delivery Innovations: http://www.doi.org/10.26538/tjnpr/v7i12.1. Trop J Nat Prod Res TJNPR. 2023;7:5341–5354.
- [6]Xu J, Xu Z, et al. A Review of the Antiviral Role of Green Tea Catechins. Mol Basel Switz. 2017;22:1337.
- [7]Steinmann J, Buer J, et al. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol. 2013;168:1059–1073.
- [8]Johari J, Kianmehr A, et al. Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus. Int J Mol Sci. 2012;13:16785–16795.
- [9]Song JM, Park KD, et al. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Antiviral Res. 2007;76:178–185.
- [10]Ryu YB, Jeong HJ, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg Med Chem. 2010;18:7940–7947.
- [11]Droebner K, Ehrhardt C, et al. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 2007;76:1–10.
- [12]Kim H-Y, Shin H-S, et al. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2008;41:122–128.
- [13]Zandi K, Teoh B-T, et al. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J. 2011;8:560.
- [14]Song W, Si L, et al. Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis. J Nat Prod. 2014;77:1632–1643. https://doi.org/10.1021/np500253m.
- [15]Lin Y-J, Chang Y-C, et al. Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods. 2012;182:93–98.
- [16]Park J-Y, Yuk HJ, et al. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem. 2017;32:504–515.
- [17]Wu L-L, Yang X-B, et al. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacol Sin. 2007;28:404–409.
- [18]Kim H-Y, Shin H-S, et al. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2008;41:122–128.
- [19]Lin C-W, Tsai F-J, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68:36–42.
- [20]Park J-Y, Kim JH, et al. Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg Med Chem. 2013;21:3730–3737.
- [21]Song J-M, Lee K-H, et al. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005;68:66–74.
- [22]Frabasile S, Koishi AC, et al. The citrus flavanone naringenin impairs dengue virus replication in human cells. Sci Rep. 2017;7:41864.
- [23]Fan W, Qian S, et al. Antiviral activity of luteolin against Japanese encephalitis virus. Virus Res. 2016;220:112–116.
- [24]Droebner K, Ehrhardt C, et al. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 2007;76:1–10.
- [25]Besednova NN, Andryukov BG, et al. Antiviral Effects of Polyphenols from Marine Algae. Biomedicines. 2021;9:200.
- [26]Stannard H, Koszalka P, et al. Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses. 2023;15:2447.